CN Stock MarketDetailed Quotes
600216 Zhejiang Medicine
- 16.54
- -0.38-2.25%
Market Closed Dec 13 15:00 CST
15.91BMarket Cap16.26P/E (TTM)
16.88High16.51Low146.15KlotVolume16.81Open16.92Pre Close243.16MTurnover1.52%Turnover Ratio37.00P/E (Static)961.64MShares19.4052wk High1.54P/B15.91BFloat Cap7.8252wk Low18.61Limit Up961.63MShs Float21.43Historical High15.23Limit Down2.19%Amplitude-2.86Historical Low0.15Dividend TTM16.64Avg Price81.38KlotAsk0.91%Div YieldTTM100Lot Size61.13KlotBid
Zhejiang Medicine Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | 11.99%6.65B | 4.36%4.15B | 8.71%2B | -3.04%7.69B | -0.61%5.93B | -0.93%3.97B | -6.77%1.84B | -10.98%7.93B | -10.99%5.97B | -6.55%4.01B |
| Refunds of taxes and levies | -24.63%219.97M | -16.75%140.97M | -27.07%48.69M | -5.86%369.12M | -9.10%291.85M | -30.06%169.34M | 25.09%66.76M | 43.00%392.12M | 50.17%321.07M | 68.53%242.11M |
| Cash received relating to other operating activities | -9.70%95.82M | -57.77%39.22M | -67.77%5.82M | 70.46%173.04M | -10.43%106.11M | 86.26%92.87M | -58.74%18.05M | -49.44%101.51M | -8.28%118.47M | -56.20%49.86M |
| Cash inflows from operating activities | 9.94%6.96B | 2.16%4.33B | 6.75%2.05B | -2.29%8.24B | -1.21%6.33B | -1.56%4.23B | -7.05%1.92B | -10.23%8.43B | -9.09%6.41B | -5.43%4.3B |
| Goods services cash paid | 5.97%3.95B | 4.74%2.51B | 11.56%1.27B | -5.96%4.59B | -6.03%3.73B | -11.40%2.4B | -21.32%1.14B | -6.08%4.88B | -3.62%3.97B | 11.46%2.71B |
| Staff behalf paid | 1.88%772.63M | -0.09%549.94M | 3.95%332.63M | 6.71%967.76M | 9.68%758.37M | 7.81%550.45M | 4.86%320M | 11.48%906.91M | 14.25%691.42M | 13.64%510.56M |
| All taxes paid | 4.60%491.76M | -0.08%324.77M | -11.01%168.07M | -27.76%532.17M | -24.73%470.16M | -33.08%325.03M | -7.99%188.86M | 11.85%736.68M | -0.40%624.65M | 32.81%485.7M |
| Cash paid relating to other operating activities | 9.27%1.06B | 3.03%731.36M | 1.33%262.71M | 9.21%1.51B | -2.07%965.61M | 16.66%709.85M | -11.52%259.26M | -12.59%1.39B | -21.11%986M | -28.23%608.46M |
| Cash outflows from operating activities | 5.88%6.27B | 3.37%4.12B | 6.65%2.03B | -3.88%7.6B | -5.54%5.92B | -7.61%3.98B | -15.26%1.9B | -4.17%7.91B | -4.99%6.27B | 5.38%4.31B |
| Net cash flows from operating activities | 68.51%692.06M | -17.06%209.39M | 16.23%23.17M | 21.84%634.31M | 190.83%410.7M | 3,137.90%252.46M | 111.26%19.93M | -54.20%520.6M | -68.84%141.22M | -101.81%-8.31M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | 102.99%290.64M | 88.42%221.82M | 130.09%125.63M | -56.26%191.79M | -61.31%143.18M | -40.61%117.73M | -36.16%54.6M | 37.50%438.5M | 64.51%370.08M | 67.12%198.23M |
| Cash received from returns on investments | 199.98%2.24M | -5.25%704.28K | ---- | -55.70%777.34K | -56.33%746.33K | -54.87%743.32K | ---- | -11.35%1.75M | -79.97%1.71M | -76.24%1.65M |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | 10.16%193.98M | 9.96%194.84M | 77,124.81%193.92M | 2,324.60%174.48M | 2,262.10%176.09M | 2,292.51%177.19M | -95.72%251.11K | 3.18%7.2M | 20.19%7.45M | 22.39%7.41M |
| Net cash received from disposal of subsidiaries and other business units | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --9.12M | 225.45%8.78M | 244.17%9.28M |
| Cash received relating to other investing activities | -38.57%462.97M | -48.41%273.55M | -61.80%151.07M | -12.63%901.72M | 52.41%753.68M | 46.92%530.21M | 55.51%395.43M | 2.74%1.03B | -36.82%494.51M | 20.89%360.89M |
| Cash inflows from investing activities | -11.54%949.82M | -16.34%690.9M | 4.52%470.62M | -14.77%1.27B | 21.66%1.07B | 43.02%825.87M | 38.53%450.29M | 11.72%1.49B | -13.91%882.54M | 33.42%577.45M |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | -25.73%473.74M | -30.17%324.1M | -22.81%170.6M | -18.35%796.87M | -8.46%637.9M | -13.62%464.17M | -36.11%221M | 3.87%975.99M | 0.06%696.85M | 10.35%537.35M |
| Cash paid to acquire investments | 118.28%291.46M | 83.49%217.9M | 142.64%122.25M | -41.59%208.75M | -57.71%133.53M | -39.53%118.76M | -48.18%50.38M | 26.79%357.38M | 60.52%315.77M | 75.96%196.39M |
| Cash paid relating to other investing activities | -31.37%467.84M | -34.67%316.56M | -46.07%120M | -30.60%781.73M | 17.81%681.73M | 139.51%484.53M | 58.93%222.5M | 18.08%1.13B | -29.43%578.68M | -53.81%202.3M |
| Cash outflows from investing activities | -15.15%1.23B | -19.57%858.56M | -16.41%412.85M | -27.34%1.79B | -8.68%1.45B | 14.04%1.07B | -15.30%493.88M | 6.20%2.46B | -7.11%1.59B | -9.70%936.05M |
| Net cash flows from investing activities | 25.36%-283.22M | 30.60%-167.66M | 232.54%57.78M | 46.60%-518.59M | 46.46%-379.47M | 32.63%-241.59M | 83.11%-43.59M | 1.27%-971.15M | -3.02%-708.77M | 40.61%-358.6M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | ---- | ---- | ---- | -86.31%55.06M | -88.09%55.06M | -9.28%55.06M | ---- | -8.13%402.24M | 8.14%462.09M | -85.80%60.69M |
| -Including: Cash received from capital contributions by minority shareholders of subsidiaries | ---- | ---- | ---- | -86.31%55.06M | -86.31%55.06M | 7,339.87%55.06M | ---- | -8.13%402.24M | -5.89%402.15M | -99.83%740K |
| Cash from borrowing | 21.25%485M | 61.67%485M | 185.00%285M | -7.69%600M | -38.46%400M | -25.00%300M | -33.33%100M | 12.07%650M | 12.07%650M | 21.21%400M |
| Cash received relating to other financing activities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 302.06%70.69M | ---- | ---- |
| Cash inflows from financing activities | 6.58%485M | 36.60%485M | 185.00%285M | -41.67%655.06M | -59.08%455.06M | -22.93%355.06M | -52.37%100M | 8.45%1.12B | 10.40%1.11B | -39.17%460.69M |
| Borrowing repayment | 34.25%537M | 61.67%485M | 135.00%235M | -17.34%600M | -41.17%400M | -37.49%300M | 16.43%100M | 3.68%725.89M | 35.98%679.89M | 139.95%479.89M |
| Dividend interest payment | -11.22%165.93M | -4.99%15.44M | -6.80%6.72M | -44.93%193.85M | -45.65%186.9M | -4.32%16.25M | -14.98%7.21M | 32.80%352M | 35.80%343.85M | -29.44%16.98M |
| -Including:Cash payments for dividends or profit to minority shareholders | ---- | ---- | ---- | 113.73%1.93M | ---- | ---- | ---- | -81.90%904.77K | ---- | ---- |
| Cash payments relating to other financing activities | 1,537.56%29.37M | 1,664.48%29.37M | ---- | 133.90%2.64M | --1.79M | --1.66M | ---- | 135.81%1.13M | ---- | ---- |
| Cash outflows from financing activities | 24.39%732.29M | 66.65%529.8M | 125.46%241.72M | -26.18%796.48M | -42.50%588.69M | -36.02%317.91M | -22.52%107.21M | 11.74%1.08B | 35.89%1.02B | 121.60%496.87M |
| Net cash flows from financing activities | -85.05%-247.29M | -220.62%-44.8M | 699.85%43.28M | -422.06%-141.43M | -251.25%-133.64M | 202.65%37.14M | -110.08%-7.21M | -37.04%43.91M | -65.21%88.36M | -106.79%-36.19M |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | 0.72%14.15M | -44.96%11.89M | 101.61%44.69K | -37.33%47.64M | -9.09%14.04M | 2,855.37%21.6M | 64.28%-2.77M | 195.21%76.01M | 227.94%15.45M | 107.75%731.01K |
| Net increase in cash and cash equivalents | 298.84%175.69M | -87.34%8.82M | 469.36%124.27M | 106.63%21.93M | 80.95%-88.36M | 117.30%69.61M | 90.94%-33.64M | -331.40%-330.62M | -6,713.85%-463.75M | -206.34%-402.36M |
| Add:Begin period cash and cash equivalents | 1.53%1.46B | 1.53%1.46B | 1.53%1.46B | -18.69%1.44B | -18.69%1.44B | -18.69%1.44B | -18.69%1.44B | 8.79%1.77B | 8.79%1.77B | 8.79%1.77B |
| End period cash equivalent | 21.19%1.64B | -2.58%1.47B | 12.81%1.58B | 1.53%1.46B | 3.43%1.35B | 10.35%1.51B | 0.50%1.4B | -18.69%1.44B | -20.08%1.3B | -31.83%1.37B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CN
Overall
Symbol
Price
% Chg
No Data
